Showing results (51-60 of 348) with videos related to
Sort By:
Pageof 35
Oncogene|October 4, 2006
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myelomaD Chauhan, M Velankar, M Brahmandam, et al.Apoptosis : an International Journal on Programmed Cell Death|March 9, 2004
2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27D Chauhan, G Li, D Auclair, et al.Cancer Research|March 30, 1999
Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cellsD Chauhan, T Hideshima, S Treon, et al.Oncogene|December 22, 1999
RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cellsD Chauhan, T Hideshima, P Pandey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemiaM Urashima, G Teoh, A Ogata, et al.Blood|January 29, 2000
CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell linesG Teoh, Y T Tai, M Urashima, et al.Blood|July 29, 1998
MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cellsM Urashima, G Teoh, D Chauhan, et al.Blood|February 25, 1999
Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequencesN Raje, J Gong, D Chauhan, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damageY T Tai, G Teoh, B Lin, et al.Journal of Clinical Pharmacy and Therapeutics|July 11, 2008
Factors affecting the uptake of new medicines in secondary care - a literature reviewD Chauhan, A MasonPageof 35